ATC code M04

ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[4]

ATC code M: Musculo-skeletal system
Other ATC codes

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M04A Antigout preparations

M04AA Preparations inhibiting uric acid production
M04AA01 Allopurinol
M04AA02 Tisopurine
M04AA03 Febuxostat
M04AA51 Allopurinol, combinations

M04AB Preparations increasing uric acid excretion
M04AB01 Probenecid
M04AB02 Sulfinpyrazone
M04AB03 Benzbromarone
M04AB04 Isobromindione
M04AB05 Lesinurad

M04AC Preparations with no effect on uric acid metabolism
M04AC01 Colchicine
M04AC02 Cinchophen

M04AX Other antigout preparations
M04AX01 Urate oxidase
M04AX02 Pegloticase

References
  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.